Logo image of DH

DEFINITIVE HEALTHCARE CORP (DH) Stock Price, Quote, News and Overview

NASDAQ:DH - Nasdaq - US24477E1038 - Common Stock - Currency: USD

5.15  +0.4 (+8.42%)

After market: 5.15 0 (0%)

DH Quote, Performance and Key Statistics

DEFINITIVE HEALTHCARE CORP

NASDAQ:DH (2/4/2025, 8:00:01 PM)

After market: 5.15 0 (0%)

5.15

+0.4 (+8.42%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week High10.62
52 Week Low3.19
Market Cap798.15M
Shares154.98M
Float46.70M
Yearly DividendN/A
Dividend YieldN/A
PE15.15
Fwd PE16.97
Earnings (Next)02-20 2025-02-20/amc
IPO09-15 2021-09-15


DH short term performance overview.The bars show the price performance of DH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

DH long term performance overview.The bars show the price performance of DH in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of DH is 5.15 USD. In the past month the price increased by 18.12%. In the past year, price decreased by -44.86%.

DEFINITIVE HEALTHCARE CORP / DH Daily stock chart

DH Latest News, Press Releases and Analysis

News Image
7 days ago - Definitive Healthcare Corp.

Definitive Healthcare named a 2025 Best Places to Work in Boston by Built In

FRAMINGHAM, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today...

News Image
a month ago - Definitive Healthcare Corp.

Definitive Healthcare to Present at the 27th Annual Needham Growth Conference

FRAMINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare...

News Image
3 months ago - Definitive Healthcare Corp.

Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024

Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization

News Image
3 months ago - Definitive Healthcare Corp.

Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024

Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization...

DH Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 37.34 37.89B
DOCS DOXIMITY INC-CLASS A 52.46 10.97B
WAY WAYSTAR HOLDING CORP N/A 7.07B
CERT CERTARA INC 35.54 2.23B
GDRX GOODRX HOLDINGS INC-CLASS A 15.06 1.84B
SDGR SCHRODINGER INC N/A 1.82B
TDOC TELADOC HEALTH INC N/A 1.79B
PHR PHREESIA INC N/A 1.67B
EVH EVOLENT HEALTH INC - A 11.26 1.19B
HSTM HEALTHSTREAM INC 51.28 1.01B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 965.28M
SLP SIMULATIONS PLUS INC 88.75 713.20M

About DH

Company Profile

DH logo image Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. The company is headquartered in Framingham, Massachusetts and currently employs 830 full-time employees. The company went IPO on 2021-09-15. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. The company transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. All of its business is conducted through AIDH TopCo, LLC (Definitive OpCo).

Company Info

DEFINITIVE HEALTHCARE CORP

492 Old Connecticut Path, Suite 401

Framingham MASSACHUSETTS US

CEO: Jason Krantz

Employees: 950

Company Website: https://ir.definitivehc.com/

Investor Relations: https://ir.definitivehc.com/

Phone: 15087204224

DH FAQ

What is the stock price of DH?

The current stock price of DH is 5.15 USD.


What is the symbol for DEFINITIVE HEALTHCARE CORP stock?

The exchange symbol of DEFINITIVE HEALTHCARE CORP is DH and it is listed on the Nasdaq exchange.


On which exchange is DH stock listed?

DH stock is listed on the Nasdaq exchange.


Is DH a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for DH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of DH.


Does DH stock pay dividends?

DH does not pay a dividend.


When does DH stock report earnings?

DH will report earnings on 2025-02-20, after the market close.


What is the Price/Earnings (PE) ratio of DH?

The PE ratio for DH is 15.15. This is based on the reported non-GAAP earnings per share of 0.34 and the current share price of 5.15 USD.


What is the Short Interest ratio of DH stock?

The outstanding short interest for DH is 4.5% of its float.


DH Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to DH. When comparing the yearly performance of all stocks, DH is a bad performer in the overall market: 80.18% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

DH Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to DH. While DH seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DH Financial Highlights

Over the last trailing twelve months DH reported a non-GAAP Earnings per Share(EPS) of 0.34. The EPS increased by 13.33% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -30.83%
ROE -71.92%
Debt/Equity 0.46
Chartmill High Growth Momentum
EPS Q2Q%11.11%
Sales Q2Q%-4.02%
EPS 1Y (TTM)13.33%
Revenue 1Y (TTM)3.96%

DH Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 75% to DH. The Buy consensus is the average rating of analysts ratings from 22 analysts.

For the next year, analysts expect an EPS growth of 18.16% and a revenue growth -0.43% for DH


Ownership
Inst Owners44.82%
Ins Owners3.2%
Short Float %4.5%
Short Ratio3.6
Analysts
Analysts75.45
Price Target5.36 (4.08%)
EPS Next Y18.16%
Revenue Next Year-0.43%